The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy, safety, and determination of RP2D of ABBV-383, a BCMA bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).
 
Cesar Rodriguez Valdes
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Takeda
 
Peter M. Voorhees
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Oncopeptides
Other Relationship - Bristol-Myers Squibb
 
Anita D'Souza
Consulting or Advisory Role - Janssen Oncology; Kedrion Biopharma; Pfizer; Prothena
Research Funding - Abbvie (Inst); Caelum Biosciences (Inst); Janssen Oncology (Inst); Novartis (Inst); Prothena (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst)
 
Alfred Chung
Consulting or Advisory Role - Janssen
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Caelum Biosciences (Inst); Cellectis (Inst); Janssen (Inst); k36 Therapeutics (Inst); Merck (Inst)
 
Sascha Tuchman
Honoraria - Janssen; Shattuck Labs
Speakers' Bureau - Celgene
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Sanofi (Inst)
 
Hana Safah
No Relationships to Disclose
 
John T. McKay
Consulting or Advisory Role - Bristol-Myers Squibb
 
Katja C Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Menarini; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Menarini; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Menarini; Takeda
 
Raphael Teipel
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Sanofi; Stemline Therapeutics; Takeda
Research Funding - Janssen
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Janssen
 
Neha Korde
Honoraria - Cancer Network; Clinical Care Options; Intellisphere; Onc Live; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - Abbvie; Amgen; Epizyme; Janssen
 
Ravi Vij
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; harpoon; Karyopharm Therapeutics; Legend Biotech; Pfizer; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Dava Oncology; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Orlando Felix Bueno
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Tanya Rosenberg
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Rajvineeth Kumar Pothacamury
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Akshanth Polepally
Employment - AbbVie
Stock and Other Ownership Interests - Abbvie
 
Aarif Ahsan
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Xin (Shane) Li (Lee)
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Ziyi Jin
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Chetasi Talati
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer